2026. Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center. Mediterranean Journal of Hematology and Infectious Diseases. 18, 1 (Apr. 2026). DOI:https://doi.org/10.4084/MJHID.2026.044.